Chun‐Nan Lin

2.6k citations
68 papers · 2.3k indexed · h-index 32
Topics
Bioactive natural compounds (15 papers)Natural product bioactivities and synthesis (13 papers)Natural Compound Pharmacology Studies (13 papers)
Partner nations
TaiwanUnited StatesIndia

In The Last Decade

Chun‐Nan Lin

67 papers receiving 2.2k citations

Peers

Chun‐Nan Lin
Comparison fields: 5 of 110
  • Molecular Biology 1.1k
  • Plant Science 568
  • Organic Chemistry 539
  • Pharmacology 419
  • Toxicology 209
Replace Woongchon Mar with:
Woongchon Mar South Korea
Francisco Estévez Spain
Shen‐Jeu Won Taiwan
WU Li-jun China
Cheng‐Jen Chou Taiwan
Bao‐Ning Su United States
Jong‐Keun Son South Korea
Lo‐Ti Tsao Taiwan
Yoshiteru Ida Japan
Hyen Joo Park South Korea
Chun‐Nan Lin relative to Woongchon Mar South Korea Woongchon Mar's profile →
Citations per field
00.5×1.5×1.9×
Woongchon Mar · 1×
Citations per year

Countries citing papers authored by Chun‐Nan Lin

Since Specialization
Citations

This map shows the geographic impact of Chun‐Nan Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chun‐Nan Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chun‐Nan Lin more than expected).

Fields of papers citing papers by Chun‐Nan Lin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chun‐Nan Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chun‐Nan Lin. The network helps show where Chun‐Nan Lin may publish in the future.

Co-authorship network of co-authors of Chun‐Nan Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Chun‐Nan Lin. A scholar is included among the top collaborators of Chun‐Nan Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chun‐Nan Lin. Chun‐Nan Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 3
3 8
4 13
5 48
6 31
7 9
8 37
9 65
10 33
11 15
12 214
13 36
14 9
15 60
16 24
17 48
18 49
19 39
20 50

About Chun‐Nan Lin

Chun‐Nan Lin is a scholar working on Complementary and alternative medicine, Toxicology and Pharmacology, having authored 68 papers that have together received 2.3k indexed citations. Recurring topics across this work include Bioactive natural compounds (15 papers), Natural product bioactivities and synthesis (13 papers) and Natural Compound Pharmacology Studies (13 papers). The work is most often cited by research in Toxicology (209 citations), Pharmacology (419 citations) and Biochemistry (141 citations). Chun‐Nan Lin has collaborated with scholars based in Taiwan, United States and India. Frequent co-authors include Che‐Ming Teng, Feng‐Nien Ko, Mei‐Ing Chung, Jih‐Pyang Wang, Shen‐Jeu Won, Jeh‐Jeng Wang, Jing‐Ru Weng, Chai-Ming Lu, Jih-Pyang Wang and Horng‐Huey Ko. Their work appears in journals such as PLoS ONE, The FASEB Journal and Biochemical and Biophysical Research Communications.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026